Flubromazolam is not really regarded to get any therapeutic use, is not on the WHO Design Listing of Vital Medicines and hasn't been marketed to be a medicinal product or service.A single pharmacokinetics review confirmed that a dose of 0.5 mg flubromazolam induced strong sedative effects that lasted in excess of ten h and induced partial amnesia f